|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K 16/30 | (2006.01) |
| (11) | Number of the document | 3292153 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16723968.0 |
| Date of filing the European patent application | 2016-05-04 | |
| (97) | Date of publication of the European application | 2018-03-14 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-31 |
| (46) | Date of publication of the claims translation | 2019-11-11 |
| (86) | Number | PCT/EP2016/060113 |
| Date | 2016-05-04 |
| (87) | Number | WO 2016/177846 |
| Date | 2016-11-10 |
| (30) | Number | Date | Country code |
| 15166303 | 2015-05-04 | EP | |
| 16152650 | 2016-01-25 | EP |
| (72) |
TREDER, Martin, DE
REUSCH, Uwe, DE
MARSCHNER, Jens-Peter, DE
KNACKMUSS, Stefan, DE
|
| (73) |
Affimed GmbH,
Im Neuenheimer Feld 582, 69120 Heidelberg,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | CD30XCD16A antikūno derinys su antagonistiniu antikūnu prieš PD-1 skirtas terapijai |
| COMBINATION OF A CD30XCD16A ANTIBODY WITH AN ANTI-PD-1 ANTAGONISTIC ANTIBODY FOR THERAPY |
| Payment date | Validity (years) | Amount | |
| 2025-04-24 | 10 | 231.00 EUR |
| 2026-05-04 |